Skip to content

Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults

HeART-BRAIN : Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults With and Without Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06130358
Acronym
HeART-BRAIN
Enrollment
40
Registered
2023-11-14
Start date
2024-02-01
Completion date
2025-02-01
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Atrial Fibrillation Recurrent

Keywords

Museum visits, Neurocognition, Stress, Cardiovascular functioning

Brief summary

In a recent report, the World Organization for Health provided some evidence that artistic and cultural activities can support the health and well-being of the population. Our previous research suggests that the effect of museum visits on well-being and stress might be tied to relaxing proprieties of contact with art objects, especially when the artwork is viewed with an introspective and self-reflexive approach. This study addresses the effect of a well-being museum intervention of six weeks on cerebral activity associated with artwork contemplation during a museum visit and assesses how it affects the psychological and cardiovascular health of older adults with and without atrial fibrillation. The well-being intervention will engage the participant in a series of 6 visits, in groups of 10, oriented on his feelings, impressions, and interpretations of artworks. This well-being museum intervention will be compared to visits typically provided in the museum, in a cross-over single-blinded design.

Interventions

OTHERExperimental: Well-being intervention followed by classic intervention

2 x 6 weeks of weekly museum visits

OTHERExperimental: Classic intervention followed by well-being intervention

2 x 6 weeks of weekly museum visits

Sponsors

Fonds de la Recherche en Santé du Québec
CollaboratorOTHER_GOV
Université de Montréal
CollaboratorOTHER
Mitacs
CollaboratorINDUSTRY
Louis Bherer
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men/women aged 50 and over, * Presenting normal or corrected vision and hearing, * With or without controlled Atrial fibrillation, * No specific expertise in visual arts (official degree or training relating to the visual arts), * Occasionally attended museums and exhibitions (≤ 6 times per year).

Exclusion criteria

* Score \> 5/15 on the geriatric depression scale, * Score on the telephone version of the MMSE \< 19, * Psychiatric or neurological diagnosis, * Presence of major functional limitations likely to affect the individual's ability to stand and walk independently.

Design outcomes

Primary

MeasureTime frameDescription
Change in the activity evoked within the ventrolateral prefrontal cortex during the contemplation of artworkBefore and after the 6 weeks of interventionsHemodynamic variations in the region of interest (concentration of oxygenated hemoglobin \[HbO2\], no units).

Secondary

MeasureTime frameDescription
Change in the activity evoked within the medial prefrontal cortex during the contemplation of artworkBefore and after the 6 weeks of interventionsHemodynamic variations in the region of interest (concentration of oxygenated hemoglobin \[HbO2\], no units).

Other

MeasureTime frameDescription
Change in salivary cortisol concentrationBefore and after the 6 weeks of interventionsmicrog/l
Change in emotionnal regulationBefore and after the 6 weeks of interventionsDifficulties in Emotion Regulation Scale DERS-F scale (Score ranges from 36-180, with a higher score indicating more emotion regulation problems)
Change in perceived stressBefore and after the 6 weeks of interventionsPerceived Stress Scale questionnaire (Score ranges from 0-4, with 0 no stress,1 mild stress, 3 moderate stress and 4 severe).
Change in Depressive symptomatologyBefore and after the 6 weeks of interventionsGeriatric Depression Scale questionnaire (Score ranges from 0-30, with a higher score indicating larger depressive symptomatology).
Change in Quality-of-lifeBefore and after the 6 weeks of interventions36-Item Short Form Health Survey (Scale ranges from 0-100, with a higher score indicating a better health status).
Change in Perceived social supportBefore and after the 6 weeks of interventionsLubben Social Network Scale questionnaire (Score ranges from 0-30, with a higher score indicating more social engagement).
Change in Heart rateBefore and after the 6 weeks of interventionsbpm
Change in perceived fatigueBefore and after the 6 weeks of interventionsFatigue Severity Scale (Score ranges from 9-63, with a higher score more fatigue)
Change in global cognitionBefore and after the 6 weeks of interventionsMoCA total score (Score ranges from 0-30, with a higher score indicating better performance)
Change in executive functioningBefore and after the 6 weeks of interventionsComputerized Stroop task, Reaction time (ms)
Self-reported masculinity and femininity traitBaselineShort Form Bem Sex-Role Inventory questionnaire (30 items questionnaire with 10 items assessing the femininity traits, 10 items assessing the masculinity traits, and 10 items neutral, not scored. Two scores are calculated for femininity and masculinity, respectively, and range from 10-70, whit a higher score indicating a higher femininity or masculinity trait).
Cognitive ReserveBaselineRami and colleagues' cognitive reserve questionnaire (Scale ranges from 0-26, with a higher score indicating a greater cognitive reserve).
Change in Repetitive negative thinkingBefore and after the 6 weeks of interventionsPerseverative thinking questionnaire (Score ranges from 0-60, with a higher score indicating more repetitive negative thinking).
Change in arterial pressureBefore and after the 6 weeks of interventionsmmHg

Countries

Canada

Contacts

Primary ContactEmma G Dupuy, PhD
emma.dupuy@umontreal.ca514-374-1480
Backup ContactLouis G Bherer, PhD
louis.bherer@umontreal.ca514-376-3330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026